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OligosaccharyltransferaseN-linked protein glycosylation in the endoplasmic reticulum (ER) is a conserved two phase process in eu-
karyotic cells. It involves the assembly of an oligosaccharide on a lipid carrier, dolichylpyrophosphate and
the transfer of the oligosaccharide to selected asparagine residues of polypeptides that have entered the
lumen of the ER. The assembly of the oligosaccharide (LLO) takes place at the ER membrane and requires
the activity of several speciﬁc glycosyltransferases. The biosynthesis of the LLO initiates at the cytoplasmic
side of the ER membrane and terminates in the lumen where oligosaccharyltransferase (OST) selects
N-X-S/T sequons of polypeptide and generates the N-glycosidic linkage between the side chain amide of as-
paragine and the oligosaccharide. The N-glycosylation pathway in the ER modiﬁes a multitude of proteins at
one or more asparagine residues with a unique carbohydrate structure that is used as a signalling molecule in
their folding pathway. In a later stage of glycoprotein processing, the same systemic modiﬁcation is used in
the Golgi compartment, but in this process, remodelling of the N-linked glycans in a protein-, cell-type and
species speciﬁc manner generates the high structural diversity of N-linked glycans observed in eukaryotic or-
ganisms. This article summarizes the current knowledge of the N-glycosylation pathway in the ER that results
in the covalent attachment of an oligosaccharide to asparagine residues of polypeptide chains and focuses on
the model organism Saccharomyces cerevisiae. This article is part of a Special Issue entitled: Functional and
structural diversity of endoplasmic reticulum.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
N-linked protein glycosylation of proteins occurs in all three do-
mains of life. The pathway at the periplasmicmembrane of prokaryotes
and the process at the ER membrane are considered to be homologous
[1]. The high conservation of the process across all domains of lifemakes
it possible to identify the underlying principles of the pathway and to
develop general concepts of N-linked protein glycosylation. The assem-
bly of an oligosaccharide on an isoprenoid lipid (bactoprenol in the
bacterial systems and dolichol in archaea and eukaryotes) from
nucleotide activated monosaccharides on the cytoplasmic side of
the membrane by a set of speciﬁc glycosyltransferases and the
subsequent translocation of the lipid-linked oligosaccharide is a uni-
fying scheme in all systems. In eukaryotes, the oligosaccharide is fur-
ther extended by lumen-oriented glycosyltransferases, but these
enzymes use dolichylphosphate-bound monosaccharides as sub-
strates. The acceptors of the oligosaccharide are selected asparagine
residues of polypeptide chains that have entered the periplasm or
the lumen of the ER, respectively. Oligosaccharyltransferase, the cen-
tral enzyme of the N-glycosylation pathway, catalyses the formation
of an N-glycosidic linkage of the oligosaccharide to the side-chainnal and structural diversity of
l rights reserved.amide of asparagine residues that are speciﬁed by the consensus se-
quence N-X-S/T.
Attached to the protein, the hydrophilic carbohydrates alter the bio-
physical properties of the polypeptide and thereby affect their folding
either directly [2–4] or indirectly [5]. For the later function, the deﬁned
structure of the carbohydrate is essential because in eukaryotes, pro-
cessing products serve as universal signals that display the folding sta-
tus of the underlying protein [6]. This subsequent use of a branched
carbohydrate structure as a deﬁned signalling molecule after the trans-
fer to the polypeptide requires on the one hand a high substrate speci-
ﬁcity of the oligosaccharyltransferase and a ﬁne-tuning of the temporal
order of glycosylation and polypeptide folding.2. Biosynthesis of the lipid linked oligosaccharide (LLO)
2.1. Dolichol, the lipid carrier in ER glycosylation
The isprenoid lipid dolichol serves as a carrier of the oligosaccha-
ride and it localizes the biosynthetic pathway to the membrane of
the ER. Dolichol is synthesized by cis-prenyltransferase, starting
from farnesylpyrophosphate and the sequential addition of C5 iso-
prenoid units [7,8]. Alterations in dolichol biosynthesis severely affect
the N-glycosylation process [9] and can result in a recently described
class of congenital disorders of glycosylation (CDG) [10]. However,
alterations in dolichol biosynthesis can also affect the metabolism of
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about the biological function of these isoprenoids [11,12].
Interestingly, the chain length of dolichol is species speciﬁc and it
is determined by cis-prenyltransferase [9]. It is important to note that
isporenoid lipids are used as membrane anchors in many biosynthetic
pathways that involve the translocation of monosaccharides or oligo-
saccharides across the membrane [13,14]. Bacterial O-antigen [15]
and murein biosynthesis [16] or different cell wall biogenesis path-
ways in mycobacterial cell wall biogenesis [17] are based on this prin-
ciple. It is tempting to speculate that the biophysical property of the
isoprenoid lipid plays an essential role in the translocation process
of complex molecules across the membrane [18].
2.2. The building blocks for oligosaccharide biosynthesis
The three carbohydrate building blocks of the LLO substrate (GlcNAc,
Man and Glc) emerge from the primarymetabolism and enter the path-
way as nucleotide activated sugars. UDP-GlcNAc and GDP-Man serve as
substrates for the transferases that act on the cytoplasmic side of the ER
membrane,whereasDol-P-ManandDol-P-Glc, created in the cytoplasm
fromDol-P, GDP-Man andUDP-Glc, respectively, are translocated across
the membrane and are used as substrate for the lumen-oriented
mannosyl- and glucosyltransferases. Dol-P-Man is synthesized by the
Dol-P-Man synthase, encoded by the DPM1 locus [19], whereas the
ALG5 locus encodes Dol-P-Glc synthase [20]. The translocation of
Dol-P-Man and Dol-P-Glc requires a directed transport from the cyto-
plasm to the lumen of the ER and biochemical studies indicate that
this translocation is protein-mediated but does not require ATP
[21–24]. The corresponding ﬂippases are not known and no mutant
strains with matching phenotypes have been identiﬁed. Dol-P-Man is
an essential component in yeast and a deﬁciency of Dol-P-Man synthase
yields a lethal phenotype. This is not due to the lack of Dol-P-Man for the
synthesis of the LLO because deﬁciencies of the lumen oriented
mannosyltransferases have no detrimental effect. The lethal phenotype
stems from the fact that Dol-P-Man is used as a substrate for the essen-
tial O-mannosylation of proteins [25] and the biosynthesis of
GPI-anchored proteins [26]. The situation for Dol-P-Glc is different be-
cause it is only used in the N-glycosylation pathway. A deﬁciency of
Dol-P-Glc synthase in yeast does result in a hypoglycosylation of pro-
teins but not in a severe growth phenotype. It is therefore surprising
that in the quite extensive searches for mutations affecting the
N-glycosylation pathway nomutants deﬁcient in the Dol-P-Glc ﬂippase
have been detected (the expected phenotype is similar to a deﬁciency in
the Dol-P-Glc synthase). A possible explanation is that both Dol-P-Man
andDol-P-Glc are translocated by a single ﬂippase, resulting in an essen-
tial nature of this enzyme, or there are two ﬂippases with redundant
functions. This would make it difﬁcult to identify the corresponding
locus in conventional genetic screens. Alternatively, Dol-P-Man- and
Dol-P-Glc synthase translocate their respective products.
2.3. The topology of lipid-linked oligosaccharide assembly
The bipartite nature of the LLO assembly pathway is one of the
main characteristics of the N-linked protein glycosylation process
and it has several important features (Fig. 1):
1) Two types of glycosyltransferases act on the LLO: glycosyl-
transferases that utilise nucleotide-activated sugars (in the cyto-
plasm) and glycosyltransferases that require dolichylphosphate-
bound sugars as a substrate.
2) The process requires the translocation of lipid-linked biosynthetic
intermediates across the membrane, resulting in a topologically
different location of the initiating (cytoplasm) and terminating
(lumen) steps of the pathway.
As a consequence of this bipartite pathway, the biosynthesis of
a single oligosaccharide transferred to an acceptor protein byoligosaccharyltransferase results in the translocation of 1 dolichyl-
pyrophosphate and 7 dolichylphosphate molecules from the cytoplas-
mic leaﬂet of the ER membrane to the lumen of the ER. It has been
postulated that the lipid carrier is recycled, resulting in a dolichol
cycle that transports the molecule back to the cytoplasm [9]. Phospha-
tases might be involved in this process and indeed, a deﬁciency of
a dolichylpyrophosphate phosphatase (Cwh8p) results in a severe
N-glycosylation deﬁciency [27]. The recycling of the dolichol carrier
offers the possibility to regulate the ﬂux thru the LLO biosynthetic path-
way. Under the assumption that the utilisation of the LLO substrate by
OST is the rate-limiting step of the N-glycosylation process, it is the
level of dolichylphosphate in the ER that determines the LLO substrate
level present in the cell. Such a regulatory mechanism can compensate
for the lack of a feedback regulation of the committed step of LLO bio-
synthesis (catalysed by Alg7p) that is due to the topological separation
of the initiating and the terminating steps of the pathway. Such amodel,
however, asks for a regulation of the activity of the Dol-P utilising en-
zymes [28].
It is important to note that it is not the absence of nucleotide-
activated sugars in the lumen of the ER that makes the use of
Dol-P-Man or Dol-P-Glc a prerequisite for lumen-oriented glycosyl-
transferases. It iswell established thatUDP-Glc is found in the lumen of
the ER and Golgi-localized glycosyltransferases that act on secretory
glycans all use nucleotide-activated sugars as substrates [29]. Speciﬁc
transporters ensure the availability of these components in the lumen
of the respective compartments. It has rather been speculated that the
use of dolichylphosphate-linked monosaccharides by ER-localized
glycosylatransferases reﬂects the prokaryotic origin of the process of
N-linked protein glycosylation biosynthetic pathway [1].
2.4. The assembly of the lipid-linked oligosaccharide
LLO biosynthesis is performed by a series of glycosyltransferases that
are encoded by the ALG (asparagine linked glycosylation) genes (Fig. 1).
The process is initiated by ALG7 N-acetylglucosamine-phosphate trans-
ferase that adds GlcNAc-P to Dol-P, forming the anhydride dolichyl-
pyrophosphate-GlcNAc (Dol-PP-GlcNAc). Alg7p is the target of the
well-known N-glycosylation inhibitor tunicamycin [30]. A protein com-
plex, encoded by the ALG13 and ALG14 loci transfers the second GlcNAc
residue [31–33]. Interestingly, theUDP-GlcNAc utilising enzymes form a
complex composed of Alg7p, Alg13p and Alg14p, whereby Alg14p is the
organizing subunit [34,35].
Three enzymes are responsible for the addition of 5mannose residues
using GDP-Man as a substrate. As is the case for the UDP-GlcNAc utilising
enzymes, they form a protein complex [36]. The ﬁrst Man is added to
Dol-PP-GlcNAc2 by the ALG1 encoded β-1,4 mannosyltransferase [37],
whereas the subsequent addition of the two branching mannose resi-
dues is catalysed by a single enzyme, Alg2p. The ordered addition of
α-1,3 and subsequently the α-1,6 linked mannose is mechanistically
not understood [38,39]. Elongation of the Man3GlcNAc2 pentasaccharide
is performed by theALG11 enzyme [40], resulting in theMan5GlcNAc2 ol-
igosaccharide that represents the ﬁnal product of cytoplasmic LLO
biosynthesis.
The subsequent steps in LLO biosynthesis occur at the luminal side of
the ER, requiring the translocation (ﬂipping) of the glycolipid across the
membrane [21,23,41,42]. As mentioned above, such translocation
events are characteristic for other biosynthetic pathways such as
O-antigen biosynthesis in Gram-negative bacteria [15], or murein bio-
synthesis [43], arabinomannan biosynthesis in Mycobacteria [17] and
this reaction has attracted the attention of both biochemists and genet-
icists alike. Genetic studies identiﬁed loci that encode potentialﬂippases
based on the phenotype of the corresponding loss-of-function muta-
tions. In case of the Man5GlcNAc2 ﬂippase, rft1 mutant strains prevent
N-linked protein glycosylation and accumulate the lipid-linked Man5-
GlcNAc2 oligosaccharide, the phenotypes expected for a loss of ﬂippase
function [44]. However, in vitro translocation assays reported Rft1p-
SEC59
Lumen
DPM
1
ALG5
Cytoplasm
ALG7
ALG1
ALG3 ALG9 ALG6 ALG8 ALG10ALG12
STT3
OST1
WBP1
OST3
OST6
SWP1
OST2
OST5
OST4
ALG2
ALG11
ALG9RFT1
CWH8
ALG2
ALG11
ALG13
ALG14
P
P P
P
P
PP
CTP CDP GDP- GDP
PP
UDP-UMP
UDP-
UDP
GDP-
GDP
PP
PP
PP
PP
PP
PP
PP PP PPPPPPPPPPPP
PP
P
UDP- UDP
dolichol N-acetylglucosaminea mannose glucose
a
b c
Fig. 1. The pathway of lipid-linked oligosaccharide biosynthesis and the transfer of the oligosaccharide to protein at the membrane of the endoplasmic reticulum. The topology of
lipid-linked oligosaccharide biosynthesis catalysed by glycosyltransferases that are encoded by the different ALG loci is shown. Glycosyltransferases active at the cytoplasmic side of
the ER membrane that utilise UDP-GlcNAc and GDP-Man, respectively, form two enzyme complexes indicated by a blue and a green square. After translocation of the lipid-linked
Man5GlcNAc2 oligosaccharide, further extension by lumen-oriented glycosyltransferases yields the Glc3Man9GlcNAc2 oligosaccharide (a,b and c refer to the three antennae of the
oligosaccharide) that is transferred to selected asparagine residues of translocated polypeptides by the oligosaccharyltransferase complex.
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question the function of Rft1p as a ﬂippase but also ask for a different
function of the RFT1 protein in the N-glycosylation process.
Four mannose and three glucose residues are added to the LLO
in the lumen of the ER by Dol-P-Man- and Dol-P-Glc-dependent
glycosyltransferases. These highly conserved enzymes are charac-
terised by the presence of multiple transmembrane segments and
they belong to the GT-C clade of glycosyltransferases [48]. They
are inverting enzymes that catalyse the formation of an α-glycosidic
linkage. Lumenal biosynthesis is initiated by the α-1,3 mannosly-
transferase encoded by the ALG3 locus [49], followed by the addition
of an α-1,2 linked mannose by the ALG9 mannosyltransferase [50],
resulting in the b-antenna of the oligosaccharide (see Fig. 1 for the no-
menclature of the antenna). The c-antenna is initiated by the ALG12
α-1,6 mannosyltransferase ([51] and terminated by the addition of
the α-1,2 linked mannose (catalysed by Alg9p) [50]. It is not before
the Man9GlcNAc2 oligosaccharide is ﬁnished that Alg6p initiates the
glucosylation of the a-antenna of the oligosaccharide [52]. Alg8p subse-
quently adds the second α-1,3 linked Glc residue to the LLO [53]. The
ﬁnal step in LLO synthesis, catalysed by Alg10p, attaches a third Glc res-
idue in α-1,2 linkage [54].
It is important to note that the branched nature of the oligosaccha-
ride allows for multiple biosynthetic paths after the translocation of
the oligosaccharide. However, one biosynthetic route is primarily
taken, but alternative assembly pathways can be detected in mutant
cells deﬁcient in deﬁned mannosyltransferases [55,56]. Due to the
high substrate speciﬁcity of the glycosyltransferases involved a single
linear pathway that terminates with the addition of the “capping”
α-1,2-linked glucose on the a-antenna of the oligosaccharide takes
place. It is this capping glucose that represents the key-determinant
for substrate recognition by oligosaccharyltransferase. The ordered
assembly of the lipid-linked oligosaccharide, in conjunction with the
substrate speciﬁcity of oligosaccharyltransferase favours the transfer
of completely assembled oligosaccharides to protein (Fig. 2). Deﬁ-
ciencies in late steps of LLO assembly result in the accumulation of
biosynthetic intermediates and a hypoglycosylation of proteins. It is
this hypoglycosylation and not the transfer of incomplete oligosac-
charides that is the primary cause for the severe deﬁciencies observedin patients with Congenital Disorder of Glycosylation [57]. Neverthe-
less, in view of a functional role of oligosaccharide structure in the
processing of N-glycoproteins in the ER, it is of central importance
that completely assembled oligosaccharides are transferred to protein
[5]. In view of the signalling function of the protein-bound glycan it is
noteworthy that the removal of the α-1,2-linked mannose of the
b-antenna of protein-bound N-linked glycans by ER mannosidase I
generates glycan structures that differ from biosynthetic lipid-linked
oligosaccharide intermediates [6].
3. Transfer of the oligosaccharide to
protein: oligosaccharyltransferase
3.1. Composition of oligosaccharyltransferase
Oligosaccharyltransferase (OST) is the central enzyme in the path-
way of N-linked protein glycosylation. It catalyses the transfer of the ol-
igosaccharide from the lipid carrier dolichylpyrophosphate to the amide
group of selected asparagine residues of polypeptide chains. In animal,
plants and fungi, the membrane-bound enzyme is a heterooligomeric
complex and in yeast, it consists of eight subunits, all membrane pro-
teins. STT3, OST1, OST2, WBP1 and SWP1 encode the essential subunit,
whereas depletion of either the OST3, OST4, OST5 or OST6 encoded
subunit results in a general hypoglycosylation of N-glycoproteins [58].
The complex exists in two isoforms containing either Ost6p or Ost3p
and the two isoforms differ in their polypeptide substrate speciﬁcity
[59–62]. Mammalian OST has a very similar composition and contains
proteins homologous to the yeast OST components: DAD1 (Ost2p),
N33/Tusc3 and MagT1 (Ost3p and Ost6p), OST48 (Wbp1p), ribophorin
I (Ost1p), ribophorin II (Swp1p), STT3A and STT3B (Stt3p) [63]. Mam-
malian isoforms of the OST complex contain either STT3A or STT3B
and N33/TUSC3 or MagT1, respectively [64]. Recently, two additional
components speciﬁc for the mammalian OST have been identiﬁed:
KCP2 and DC2 associate with mammalian OST complexes [65–67].
The characterisation of N-glycosylation pathways in prokaryotes and
in unicellular eukaryotes has led to the identiﬁcation of homologous
N-glycosylation pathways [1] that rely on less complex OST enzymes:
Cryptosporidium parvum encodes most of the OST subunits found in
LLO substrate recognition
Interaction with translocon
Modulation of polypeptide
substrate folding
Fig. 2. Speciﬁc functions of eukaryotic oligosaccharyltransferase. The enzyme preferentially transfers completely assembled oligosaccharides and not biosynthetic intermediates. It
can interact with the translocation machinery and it can modulate the folding of polypeptide substrates. These functions are mediated by eukaryote-speciﬁc components of the
oligosaccharyltransferase (shown in black) that form a complex with the catalytically active STT3 subunit (red).
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in Trichomonas vaginalis, Entamoeba histolytica, Plasmodium falciparum
genomes [58]. Here, homologues of Ost1p, Ost2p, Stt3p and Wbp1p
were identiﬁed. Giardia lamblia and kinetoplastids encode only STT3 ho-
mologues [58]. Some kinetoplastids encode several paralogues of STT3
that have been demonstrated to function as single subunit OSTs
[68–70] and prokaryotic OST enzymes are homologous to the eukaryotic
STT3 proteins. This phylogenetic analysis clearly identiﬁes STT3 as the
catalytically active subunit of the multimeric OST complex.
The reaction catalysed by OST is unique and it is the basis for the
“generality” of the N-linked modiﬁcation of proteins. On the one
hand, OST has high substrate speciﬁcity for the lipid-linked oligosac-
charide but it modiﬁes a large number of proteins. Glycosylation sites
are characterised by the consensus sequence NxS/T, where x can be
any amino acid except proline [71]. In the following, the speciﬁcity
of OST towards its substrates is discussed.
3.2. Substrate speciﬁcity of oligosaccharyltransferase
The LLO substrate of OST is a large and complex molecule that is an-
chored in the membrane of the ER. In vitro studies revealed Dol-
PP-GlcNAc2 is the minimal oligosaccharide structure that is accepted
by OST [72] but in vivo studies show a clear preference for the fully as-
sembled oligosaccharide and it is the terminal α-1,2 Glc residue of the
a-branch that is a key determinant for substrate recognition of OST
while theMan residues of the b- and c-branch are of limited importance
[51] (Fig. 2). However, themolecular details of LLO substrate recognition
by the multimeric OST remain unknown but a regulatory mechanism
that increases substrate speciﬁcity of OST has been proposed [73]. It is
important to note that in Trypanosoma brucei, oligosaccharyltransfrase
is a single subunit enzyme, homologous to the STT3 protein family.
Three paralogues are encoded in the genome and the corresponding
OST differ with respect to their LLO and peptide speciﬁcity [68,74].
TbSTT3A transfers the Man5GlcNAc2 oligosaccharide to selected accep-
tor sequences of a VSG protein, whereas the TbSTT3B protein utilises
the Man9GlcNAc2 LLO as a substrate to other glycosylate acceptors.
These data show that a single subunit OST is able to distinguish oligosac-
charide substrates that differ in their structure, asking for a lectin do-
main of the enzyme located at a distance from the catalytic center.
Apart from the oligosaccharidemoiety of the LLO also the lipid carrier
may interactwith the OST. In yeast, OST seems to possess certain ﬂexibil-
ity towards the length of the LLO dolichol moiety. Biosynthesis oftruncated dolichol with 11–12 isoprene units by a cis-prenyltransferase
from G. lamblia in Saccharomyces cerevisiae did not result in a
hypoglycosylation phenotype, indicating that the truncated dolichol is
sufﬁcient for the yeast OST to glycosylate proteins [75]. However, yeast
OST cannot utilise very short lipid carriers with only three to four iso-
prene units in vitro [76].
It is noteworthy that in eukaryotes the oligosaccharide transferred
to protein is remarkably conserved but shorter “high mannose” oligo-
saccharides are transferred in different protists. It has been proposed
that they represent intermediates in the evolution of the N-
glycosylation pathway [1]. Alternatively, these pathways might repre-
sent reduced forms that all originate from a Glc3Man9GlcNAc2 pathway
[77]. Irrespective of the origin of the diversity, the oligosaccharide struc-
ture transferred in the N-glycosylation pathway is remarkably con-
served in eukaryotic species.
In contrast to the LLO substrate, the polypeptide acceptor of OST
seems to be very diverse: a large number of proteins are N-glycosylated
in the secretory pathway. However, N-glycosylation sites are highly con-
served in the primary sequence of these acceptor proteins: the well
known NxS/T sequon [78] where x can be any amino acid except proline
deﬁnes a potential N-glycosylation site of proteins. The same sequon is
also present as a key determinant of N-glycosylation sites in the homolo-
gous prokaryotic N-glycosylation systems [79–81]. Based on the crystal
structure of the bacterial OST PglB from Campylobacter lari in complex
with an acceptor peptide, the substrate speciﬁcity of the N-glycosylation
system can now be explained at a molecular level. The acceptor peptide
forms a 180° turn and the hydroxyl amino acid at the +2 position is rec-
ognized by a binding pocket of the enzyme formed by a highly conserved
WWDYGmotif found in the STT3protein family [82]. Assuming that poly-
peptide substrate recognition of eukaryotic OST is similar to the bacterial
enzyme (the conserved nature of the peptide binding site supports this
hypothesis), the crystal structure of PglB explains the preferences of
NxT over NxS for OST reactivity in vitro [83] as well as the use of rare
non-canonical N-glycosylation sites found in N-glycoproteins [84–90].
NxC glycosylation sequons represent about 1% of all efﬁciently used
sites in themouse glycoproteome [90] and both in vivo and in vitro stud-
ies reveal that the NxC sequon can be viewed as an infrequently used ca-
nonical glycosylation site [91–93] whereas the detection of NG
glycosylation sequons using PNGase digestion of glycoproteins might be
due to the deamidation of asparagine–glycine sequences during sample
preparation [94]. It is important to note that not all potential
N-glycosylation sequons are glycosylated in vivo. It is estimated that
ERLumenPeriplasm
Cytoplasm
Bacteria Eukaryotes
Glycosylation
Folding
Folding
Glycosylation
Fig. 3. Schematic comparison of thebiosynthesis of N-glycoproteins in pro- and eukaryotes. In prokaryotes speciﬁc oligosaccharide is transferred by a single-subunit oligosaccharyltransferase
to folded proteins in the periplasm. In eukaryotes, themultisubunit oligosaccharyltransferase can interact with the translocationmachinery and canmodulate the folding of polypeptide sub-
strates. This can result in the modiﬁcation of proteins prior to their folding.
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oligosaccharyltransferase [90,95] and it has been postulated that se-
quences surrounding the glycosylation site affect glycosylation [96]. In ad-
dition, distance from a transmembrane domain or to the next
N-glycosylation site might inﬂuence glycosylation [97].
In the course of eukaryotic evolution, N-linked protein glycosylation
has become the most widely used protein modiﬁcation, more than
2300N-glycoproteinswith over 5000 glycosylation sites have been iden-
tiﬁed in the mouse glycoproteome [90]. It is the unique substrate speci-
ﬁcity of the oligosaccharyltransferase thatmade such awide distribution
possible. The short, linear NxS/T acceptor sequence can be inserted at
many different sites of the proteins. Indeed, the analysis of the N-
glycoproteome of different species revealed a high diversity of glycosyl-
ation sites [98], demonstrating the ﬂexible use of this modiﬁcation on an
otherwise conserved proteome. In addition, N-glycosylation is much
more frequent in multicellular than in unicellular species [98],
supporting the hypothesis that diversifying glycosylation plays a major
role in the evolution of multicellularity [99]. These data also suggest
that there is a selective pressure in the course of eukaryotic evolution
to increase the degree of N-glycosylation in secretory proteins. Due to
the short acceptor sequon only few mutations are required to alter the
N-glycosylation of a given protein, thereby changing the biophysical
property of the protein dramatically. Efﬁcient N-glycosylation of a given
site is under positive selection pressure: the preference of the NxT over
the NxS sequon found in all species so far examined [98] correlates with
the substrate speciﬁcity of OST (NxT is preferred over NxS). However,
the presence of the N-X-S/T sequon in the sequence of a polypeptide is
not sufﬁcient to deﬁne a glycosylation site. The molecular analysis of the
bacterial OST reveals that the acceptor sequence has to be located in a
ﬂexible domain of thepolypeptide [82], restricting the possible placement
of N-glycosylation sites to ﬂexible domains of proteins. Indeed, amajority
of N-glycosylation sites is found in potential loop and turn domains of
proteins, but a signiﬁcant portion of N-glycosylation sites is present in
deﬁned secondary structures of proteins and β-sheet structures are
even enriched in N-glycosylation site [98].
Therefore, protein folding can be viewed as a competing event in the
glycosylation process of sequons that end up in a structured domain of
the terminally folded protein. Accordingly, the positive selection for an
increased number of glycosylated sites in a protein results in the ar-
rangement of glycosylation before folding in the protein maturation
pathway. An altered timing of the N-glycosylation in the biogenesis of
secretory proteins can be achieved by additional functionalities of
OST, performed by additional, non-catalytic subunits of the enzyme.Indeed, an increase in the complexity of OST, together with an increase
in the number of glycosylated sites in a proteome is observed in the
course of evolution. Within the framework of this hypothesis,
non-catalytic subunits of complex OST provide additional substrate
range by modulating the folding of OST client proteins.
One direct way to time glycosylation before folding is the localisation
of OST at the translocationmachinery (Fig. 2). Nascent polypeptide chains
enter the lumen of the ER in an extended and ﬂexible conformation
[100,101], the optimal substrates for OST. Placing OST at the translocation
site also increases the local OST substrate concentration and favours the
glycosylation process. The close proximity of OST and the translocon has
been conﬁrmed experimentally: components of the OST complex have
been cross-linked to translocating ribosomes [102], antibodies directed
against the cytoplasmic domain of the OST component ribophorin I pre-
vent protein translocation [103] and OST can be found in a complex
with the translocon and the TRAP complex [66]. However, co- and
post-translocational glycosylation are not excluding each other and both
processes can take place in the ER. It has been suggested that the compo-
sition of the OST complex differs for the two modiﬁcation events: The
STT3A OST isoform glycosylates substrate polypeptide chains co-
translationally, while STT3B isoforms can glycosylate sites that were
skipped by STT3A complexes inmammalian cells [104]. A similar speciﬁc-
ity of the two distinct OST complexes has been proposed for yeast [105].
An alternativeway tomodulate the folding of client proteins is the di-
rect interaction of OST with folding intermediates (Fig. 2). The role of the
STT3 subunit as the catalytically active protein is well established
[64,69,70,79,106–108] and small subunits like Ost4p and Ost5p might
be involved in the assembly of the OST complex [58]. In contrast,
lumen-exposed domains of larger subunits can directly interact with
polypeptide substrates and prevent their folding before glycosylation
has taken place. Depletion of the mammalian ribophorin I and KCP2
subunit affected the glycosylation of only a subset of proteins [109–111]
compatible with their role as substrate-speciﬁc chaperone. An enzymati-
cally active role of one of the OST subunits has been demonstrated for the
yeast Ost6p: the luminal domain of this protein forms has a thioredoxin
fold and can function as an oxidoreductase in vitro [112]. Based on the ob-
servation that oxidative protein folding might interfere with glycosyla-
tion [113] and the analysis of glycosylation sites affected by an Ost6p
deﬁciency it has been proposed that the OST6 (and the homologue
OST3) subunit forms a transient mixed-disulphide with client proteins.
This covalent interaction modulates protein folding and may allow (or
prevent) the modiﬁcation of N-glycosylation sites that are in direct prox-
imity of cysteine residues [112].
2435M. Aebi / Biochimica et Biophysica Acta 1833 (2013) 2430–2437Within the framework of this hypothesis, N-linked protein glycosyl-
ation has evolved from the prokaryotic “folding–glycosylation” to the
eukaryotic “glycosylation–folding” process (Fig. 3). As a consequence,
many different sites in a large number of secretory proteins can be
glycosylated. In addition, this shift in the temporal order of maturation
events is a prerequisite for using N-linked glycans as “universal signals”
to modulate and control N-glycoprotein folding [6]: N-linked glycans
can direct the folding machinery to deﬁned regions of the polypeptide
and the differentially processed N-linked glycan is used as a covalently
attached signal to control and to direct the processing path of the poly-
peptide in the ER [5]. These “general” functions of the N-linked glycan
are conﬁned to the ER compartment and are a conserved feature of eu-
karyotic cells. Subsequent processing of the same N-linked glycan in a
protein-, cell- and species-speciﬁc manner in the Golgi can result in a
wide variety ofN-linked glycan structure that havemanydifferent func-
tions on (primarily) surface-exposed proteins. This additional role of
N-linked glycans adds another unique feature to this protein modiﬁca-
tion pathway and makes it possible to generate the functionally and
structurally very diverse N-glycoproteome in eukaryotic organisms.
The unique chemical properties of carbohydrates and the substrate
speciﬁcity of oligosaccharyltransferase are the molecular determinants
that make N-linked protein glycosylation the most prominent protein
modiﬁcation of eukaryotic cells.
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